OLD Category: signatures

A 17-gene stemness score for rapid determination of risk in acute leukaemia

• Ng S.W.K. et. al.,

Early Molecular Stratification of High-risk Primary Biliary Cholangitis

• Hardie C. et al.,

A transcriptional signature identifies LKB1 functional status as a novel determinant of MEK sensitivity in lung adenocarcinoma

• Kaufman J.M. et al.,

Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors

• Lalonde E. et al.,

Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma

• Chen L. et al.,

Clinically Viable Gene Expression Assays with Potential for Predicting Benefit from MEK Inhibitors

• Brant R.J. et al.,

MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines

• Fenger J.M. et al.,

Development of prognostic signatures for intermediate-risk papillary thyroid cancer

• Brannan K. et al.,

Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer

• Shukuya T et al.,

Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL

• Savage K.J. et al.,

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

• Muro K. et al.,

Transcriptome Variability in Keratocystic Odontogenic Tumor Suggests Distinct Molecular Subtypes

• Hu S. et al.,